Baidu
map

值得医护警惕的职业暴露

2014-12-29 成洁 健康界

危险的职业暴露常伴医护人员左右。 一个数据彰显其严重性:六成以上医务人员至少发生过一种以上与职业暴露有关的危险行为。他们常见的职业暴露包括感染性职业暴露、放射性职业暴露、化学性职业暴露等。世界各地医务人员因职业暴露所患的疾病中,传染病占较大比例,主要是乙型肝炎、丙型肝炎和艾滋病。预防职业暴露难在何处?国外又有哪些防控经验?一起来梳理。 到底有多严重 “你暴露了”这句话之于医务人员,随时都有可

危险的职业暴露常伴医护人员左右。

一个数据彰显其严重性:六成以上医务人员至少发生过一种以上与职业暴露有关的危险行为。他们常见的职业暴露包括感染性职业暴露、放射性职业暴露、化学性职业暴露等。世界各地医务人员因职业暴露所患的疾病中,传染病占较大比例,主要是乙型肝炎、丙型肝炎和艾滋病。预防职业暴露难在何处?国外又有哪些防控经验?一起来梳理。

到底有多严重

“你暴露了”这句话之于医务人员,随时都有可能发生。触目惊心的案例并不鲜见。

北京地坛医院骨科主任张强曾给艾滋病患者做手术时,不小心被手术刀划破手指,事后服用艾滋病药干预,出现腹泻、乏力等严重药物副作用。所幸在服药3个月后HIV阴性。

深圳儿童医院神外科曾接诊一名颅脑出血的患儿,由于时间紧迫来不及验血,其母亲也明确说患儿无任何传染病,于是医护人员均身着普通防护装置抢救患儿。当抢救完毕准备手术化验时,却查出该患儿患有艾滋病。这个意外发现,让6名参与抢救及后期采血的医护人员瞬间陷入恐慌。

武汉某医院也曾发生严重的放射性职业暴露,该院妇产科女医生甲状腺结节的发病率高达90%,其中在四层23号和24号手术室工作过的44岁以上4名女教授,全部患甲状腺癌,无一幸免。

类似情况在医院并不少见。成都市第五人民医院最新发表的一组研究数据显示,护士发生职业暴露的比率高达52.3%,是医院内发生职业暴露最多的人群;医生占21.6%;实习生占20.5%。而42.1%的职业暴露由接触过明确病原体患者的针头器械导致。

美国疾病预防控制中心对医疗机构疾病检测的统计结果更为精确:医务人员经皮暴露的艾滋病病毒感染率为0.3%,发生针刺损伤后丙型肝炎病毒的感染率为2%,乙型肝炎病毒的感染率为6%~30%。

更为严重的是,鉴于职业性质,医护人员患上传染病比常人更具危害性。“医护人员具有传染病易感者和传染源的双重身份,做好医护人员的职业防护,不但能保护医护人员,更是保护广大患者,具有非常重要的临床意义。”中国疾病预防控制中心职业卫生与中毒控制所王焕强教授在一次受访时强调。

预防难在哪里

职业暴露如此危险,何以还频频发生?

首先,因社会多少存在歧视意识,许多艾滋病、梅毒等传染性疾病患者不愿意向医护坦陈病史。虽然我国目前对艾滋病患者实施跟踪管理,许多人仍游离于管理范围之外。特别是当遇到一些紧急情况,需要在血液检查结果出来前就实施手术或治疗,这样极易造成医护人员的职业暴露。值得一提的是,若患者隐瞒病情造成医护人员感染将承担什么责任,目前法律法规对此尚存在空白。

其次,我国大多数医务人员对职业暴露的危险性认识不足。比如,临床上常见医务人员给输完液的患者拔针时,被剩余的药剂溅到;手术时,即使做好防护措施,锋利的器械仍容易割破手套等。

2013年,一项针对国内4家大型综合医院的相关调查显示,在可能暴露于患者血液和体液的情况下,只有30%的医务人员每次都能坚持佩戴眼罩,15%的人从来不戴眼罩;只有28.7%的医务人员每次都穿防护服,15%的人从来都不穿。

再次,很多医院职业防护观念落后,不仅培训不到位,就连职业防护基础设施、设备的投入也甚微。要想做好职业防护,医院必须完善个人防护用品的规范配置,以及明晰医院建筑设计及特种设备安装使用规范。但是,做好这些事情需要不菲的资金,而政府又几乎没有投入,有些基层医院为了保证运营,只能在防护措施上打折扣,严格说来,要真正达到传染病的隔离消毒要求,国内很多大型综合性医院也达不到标准。

如果医院不能加强职业暴露预防资金的投入,给职工提供一个安全的工作环境,医务人员就会长期处于职业暴露的危险状态,出现职业暴露的事件也就不足为奇。

美国医院防控经验

2000年11月6日,美国时任总统克林顿签署世界上首部关于医务人员针刺伤职业暴露防护的国家级法案——《针刺安全预防法》。随后,中国疾病预防控制中心职业卫生所有关专家对此深入研究,意在借鉴美国的立法经验,为我国的立法提供参考。

据美国职业安全与卫生署估计,该国医护人员每年约发生60万次针刺损伤。有些组织还指出,美国每年有1000名医护人员因针刺损伤导致感染严重疾病。鉴于这些情况,相关行业组织积极游说,要求立法保障实施安全注射、使用能减少损伤性能的针具或无针系统等。1998年,美国加利福尼亚州率先实施该法律。1999年,众议员PeteStark提交“医护人员针刺预防法(1999)”提案。基于此,克林顿最终签署《针刺安全预防法》。

美国传染病中心很早之前的一项研究表明,使用安全针具抽血能够将针刺损伤发生率降低27%?76%。另一项研究结果显示,约83%带针管的针具可以预防刺伤。克林顿签署《针刺安全预防法》,很大程度上保障了这些建议落地。

同样值得一提的是,美国越来越多的州还对伤残和工作人员的赔偿予以明确和细化,这是美国对职业暴露问题认识不断深化的体现。毫无疑问,保证医务人员的职业安全,就是保证全体公民的生命安全。对于立法为医务人员生命安全筑起保护屏障,应提到全民生命安全的高度来认识。国内多位专家表示,像美国一样由国家立法保护医务人员的职业安全,让与此相关的“防”和“护”逐步落地是最理想的途径。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2016-01-11 medsic

    完全不能避免,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2016-01-11 medsic

    完全不能避免,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2016-01-11 medsic

    无法避免,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2016-01-11 medsic

    嗯,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2016-01-11 medsic

    了解

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2016-01-11 medsic

    了解

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2016-01-11 medsic

    感谢分享~

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2016-01-11 medsic

    感谢分享~

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2015-02-16 Johnny1989

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=55892, encodeId=9a84558921a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55893, encodeId=089c558933a, content=完全不能避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55894, encodeId=1da955894c2, content=无法避免,, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55895, encodeId=dc6b5589538, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55896, encodeId=16d955896f0, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55897, encodeId=5a115589eb7, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55898, encodeId=470c55898c5, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55899, encodeId=1e90558993d, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:07:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16084, encodeId=8f4116084e8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:37:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15563, encodeId=45bd1556333, content=恩恩, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:56:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2015-02-15 jianlion

    恩恩

    0

相关资讯

视频: 时间都去哪儿了(医护版MV)——荆门市第一人民医院

医护版《时间都去哪儿了》通过一个个镜头的剪辑记录,为广大观众揭秘了日夜工作在ICU、急救车、手术台等岗位上白衣天使们的真实状态。四分钟的MTV的 艺术演绎,勾勒出医务人员们无怨无悔的奉献之志和渴望与患者为友的真情。“悬壶济世度芳华,风霜雨雪几春夏”这些歌词都是医护人员的真实写照和心声

全副武装:埃博拉医护人员的装备(图说)

一个圆顶头盔、一双厚靴子以及裹住全身的特殊塑料外衣——这身装备是为英国医护人员避免感染埃博拉而专门设计的,因为他们要前往如今人们敬而远之的西非的部分埃博拉疫区国家。 这周英国政府部署了第一波NHS(英国国家医疗服务)志愿者去往塞拉利昂与各国的志愿者们一起支援当地,帮助控制埃博拉疫情。团队共三十人,由普通科医生、护士、精神科医师以及急诊医学顾问组成。 志愿者队伍到

幽默一笑:怎么证明运动不减肥?

1、运动不减肥医生说:要清除你多余的脂肪,唯一的方法就是多运动。病人说:我的妻子每天说话真多,她的下巴怎么还是两层?2、该洗澡了一个学生去看医生,医生检查后说:“没关系,注射一针就好了。”医生拿药棉在学生手臂上擦擦,如此反复三四次。学生以为病重,担心地问:“医生,问题严重吗?”医生认真地说:“同学,你该洗澡了。”3、精神病评估精神病院里有三个患者最近给医护人员惹了很多麻烦,于是院方找了一个专家来评

昆明救治医疗系统总动员:72小时的考验

从3月1日昆明暴力恐怖袭击事件发生至今,医务人员一直坚守在一线,竭力抢救伤者,为挽救生命尽着最大的努力。 第一时间 医务人员被紧急召回 3月1日,正好轮到云南省第三人民医院胸外科医生章锐值夜班。晚上9时多,他接到了急诊科请求支援的电话。 云南省第三人民医院是距离火车站最近的医院,因此,这里是最先接收大批伤员的地方。赶到急诊的章锐被眼前的场景震惊了:医院门

五部委联手打击六类涉医违法犯罪

2014年04月24日,最高法院会同最高检察院、公安部、司法部、国家卫生和计划生育委员会联合发布《关于依法惩处涉医违法犯罪维护正常医疗秩序的意见》。《意见》规定,要重点打击在医院私设灵堂扰序等六类涉医违法犯罪行为。 据最高法院发言人孙军工介绍,《意见》明确了“严格执法”的方针——对于医疗机构及其医务人员在治疗过程中并无过错,被告人无端猜疑,蓄意报复,犯意坚决,采取残忍手段杀害、伤

卫计委:莫把疾病后果简单归咎医护!

国家卫生计生委新闻发言人姚宏文今日在谈及医患关系时指出,医学不是万能的,医生也不是神,不要盲目的把疾病引发的不良后果简单的归咎于医护人员的责任和技术水平。国家卫生计生委今日召开例行新闻发布会,介绍科学就医主题宣传教育活动及全国大型义诊活动周的相关情况。在谈及医患关系问题时,姚宏文强调,打砸医院伤害医务人员是严重的违法犯罪行为,应当受到法律的严惩,应当由有关部门追究犯罪分子的法律责任。姚宏文表示,我

Baidu
map
Baidu
map
Baidu
map